Chemists have developed a revolutionary new way to manufacture natural chemicals by clipping smaller molecules together like Lego. They have used the new method to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria, pseudopterosin.
“We took small molecules and clipped them together like Lego,” said lead researcher Professor Michael Sherburn, from the Research School of Chemistry.
“The building blocks are carefully designed in such a way that the first reaction generates a product perfectly primed for the second. It’s quite magical. This means you can efficiently build large and complex molecules.”
Medicines of this type have traditionally been made in a cumbersome way. Chemists take a related molecule and renovate it. This is a lengthy process, with unwanted structural features being ripped out and replaced.
“This leads to a lot of waste,” Professor Sherburn said.
The group trialed their innovative new method by making pseudopterosin, a powerful anti-inflammatory and analgesic drug, which is currently only available in tiny quantities extracted from fan coral found in the Bahamas.
The work began as blue-sky research, with the researchers trying to work out a way to make supposedly impossible molecules of cross-conjugated hydrocarbons.
Before trying the experiments the team ran simulations on the Raijin supercomputer, which indicated that their method had potential.
“Ours is an empowering and enabling technique, allowing a smarter and faster way to make important substances,” said Dr Chris Newton, who did the research in the laboratory as a PhD student.
The Latest on: Manufacturing new drugs
via Google News
The Latest on: Manufacturing new drugs
- Topical Drug Delivery System Market Size, Share, Trends, Analysis, Scope, Overview, Application, Forecasts by 2023on July 5, 2019 at 6:04 pm
New York, NY -- (SBWIRE ... Chapter Two Manufacturing Technology of Topical Drug Delivery System 2.1 Development of Topical Drug Delivery System Manufacturing Technology 2.2 Analysis of Topical Drug ... […]
- Transdermal Drug Delivery Market Will Observe Exponential Growth and Opportunities 2018-2023on July 5, 2019 at 5:54 pm
New York, NY -- (SBWIRE ... Chapter Two Manufacturing Technology of Transdermal Drug Delivery 2.1 Development of Transdermal Drug Delivery Manufacturing Technology 2.2 Analysis of Transdermal Drug ... […]
- Takeda opens new cancer drug plant in Dublinon July 5, 2019 at 9:15 am
Japanese pharma group Takeda opened a new state-of-the-art cancer drug manufacturing plant in Dublin on Friday. The €40 million plant will be used to manufacture global supplies of the company ... […]
- Why aren’t Democrats discussing financed drug research?on July 5, 2019 at 4:42 am
It is rare that the manufacturing and distribution process involves major ... and its supporters in Congress try to pretend that we couldn’t possibly develop new drugs without the incentive of patent ... […]
- BioInvent Receives Milestone Payment Related to TAK-169 Investigational New Drug Applicationon July 4, 2019 at 4:05 am
today announced it will receive a $0.5 million milestone payment related to the acceptance by the U.S. Food and Drug Administration of the Investigational New Drug (IND) application for TAK-169 ... […]
- Global Blood Therapeutics: Voxelotor Can Take The Stock Price To New All-Time Highson July 3, 2019 at 6:14 am
The FDA assigns Subpart H for all new drugs that address serious or life ... more capital to finance its commercial activities or manufacturing costs. The FDA has granted the company accelerated ... […]
- RedHill Biopharma Announces FDA Acceptance of New Drug Application for Talicia®on July 3, 2019 at 4:00 am
1 Talicia® (RHB-105) is an investigational new drug, not available for commercial distribution.2 Lamb A et al. Role of the Helicobacter pylori‐induced inflammatory response in the development of ... […]
- Manufacturing News of Note: APAC adds 50 jobs at Virginia site; New sterile injectable CMO formson June 27, 2019 at 6:26 am
Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered ... […]
- NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan)on June 26, 2019 at 9:18 pm
Established in 2011, Innovent is committed to developing, manufacturing and commercializing ... three monoclonal antibodies have their New Drug Application (NDA) under review and two of them ... […]
- Akorn gets FDA's warning letter related to New Jersey manufacturing planton June 25, 2019 at 9:45 am
June 25 (Reuters) - Akorn Inc said on Tuesday the U.S. Food and Drug Administration has raised certain issues related to the inspection of its Somerset, New Jersey manufacturing facility in July and ... […]
via Bing News